Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Journal of Endocrinology|August 6, 2009
Lipoatrophy in GH deficient patients treated with a long-acting pegylated GHPhilippe Touraine, Gwyn A D'Souza, Ione Kourides, et al.
The Journal of Clinical Endocrinology and Metabolism|March 26, 2010
Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiencyMaria Kołtowska-Häggström, Mitchell E Geffner, Peter Jönsson, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2014
Primary treatment regimen and diabetes insipidus as predictors of health outcomes in adults with childhood-onset craniopharyngiomaKevin C J Yuen, Maria Kołtowska-Häggström, David M Cook, et al.
European Journal of Endocrinology|June 24, 2006
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysisRoger Abs, Ulla Feldt-Rasmussen, Anders F Mattsson, et al.
European Journal of Endocrinology|December 26, 2001
Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's diseaseUlla Feldt-Rasmussen, Roger Abs, Bengt-Ake Bengtsson, et al.
European Journal of Endocrinology|August 19, 2008
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trialsCamilo Jimenez, Pia Burman, Roger Abs, et al.
European Journal of Endocrinology|March 30, 2012
Overall and cause-specific mortality in GH-deficient adults on GH replacementRolf C Gaillard, Anders F Mattsson, Ann-Charlotte Akerblad, et al.
Clinical Endocrinology|August 5, 2006
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomasFelipe F Casanueva, Mark E Molitch, Janet A Schlechte, et al.
Pageof 4